dHMN-7B

DCTN1 | 2003

What Is dHMN-7B?

dHMN-7B is a type of CMT caused by autosomal dominant mutations in the DCTN1 gene. This gene provides instructions for making a component of dynactin, part of the transport machinery that moves cargo along the length of motor nerve axons. Mutations in the DCTN1 gene disrupt this function, leading to impaired nerve signal transmission.

dHMN-7B is autosomal dominant, meaning that just one of the gene’s two copies needs a mutation to cause this subtype.

Clinical Features

The age of symptom onset in dHMN-7B is variable, ranging from childhood to adulthood. As a motor neuropathy, dHMN-7B primarily affects the most distal points, with weakness and atrophy of the feet and hands, and little to no involvement of the sensory nerves. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

dHMN-7B symptoms may include:

  • Weakness and atrophy in the feet and lower legs
  • Foot drop
  • Reduced or absent reflexes
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

dHMN-7B shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
dHMN-7B

Classification
dHMN/HMN

Neuropathy Type
Axonal

Inheritance Pattern
autosomal dominant

Genetic Context

HGNC-Approved Gene Symbol
DCTN1

Gene Full Name
dynactin subunit 1

Chromosome
2p13.1

Zygosity of Responsible Variant
Heterozygous

Variant Mechanism

Dominant-Negative

Details

Confidence:
Medium

Prediction:
The evidence supports a dominant-negative mechanism for dHMN-7B: the CAP-Gly substitution p.Gly59Ser destabilizes the microtubule-binding domain of p150glued, and the misfolded subunit both assembles into dynactin and accumulates in cytoplasmic aggregates that draw normal p150glued in with it, so retrograde transport degrades further than one working allele would predict. While aggregates keep sequestering normal subunit, added wild-type p150glued is not predicted to rescue transport. Other dominant DCTN1 alleles cause Perry syndrome, and no recessive DCTN1 disease supports a haploinsufficiency route to this phenotype.

Rationale:
Aggregated Gly59Ser p150glued withdraws normal subunit from circulation, so the cell loses more dynactin activity than one mutant allele accounts for, and retrograde transport fails in the motor neurons that declare themselves here as vocal cord paralysis and hand wasting. Whether those aggregates additionally act as a toxic species, independent of what they sequester, is unsettled.

ClinVar Pathogenic Variants

View DCTN1 ClinVar Variants

dHMN-7B OMIM Entry

dHMN-7B OMIM

DCTN1 OMIM Entry

DCTN1 OMIM

More Info

dHMN-7B Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

Mutant Dynactin in Motor Neuron Disease

Authors

Puls, I., Jonnakuty, C., LaMonte, B. H., Holzbaur, E. L., Tokito, M., Mann, E., Floeter, M. K., Bidus, K., Drayna, D., Oh, S. J., Brown, R. H., Jr, Ludlow, C. L., & Fischbeck, K. H.

Publication Date
March 10, 2003

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.